Top Markets
Coin of the day
Marvel Biosciences Corp. Marvel Biosciences Corp.

Marvel Biosciences Corp.

MRVL
Rank in Stocks #33329
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical... Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The companyโ€™s lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimerโ€™s disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.
Share Price
$0.12476927
Last synced: 2026-08-14
Market Cap
$7.86M
Change (1 day)
6.25%
Change (1 year)
-19.80%
Country
CA
Trade Marvel Biosciences Corp. (MRVL)

Category

Stock split history for Marvel Biosciences Corp. (MRVL)
Marvel Biosciences Corp. stock (symbol: MRVL) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 17, 2026.
One MRVL share bought prior to Aug 17, 2026 would equal to 0 MRVL shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE